| 000 | 01770 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517164147.0 | ||
| 264 | 0 | _c20180417 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a1873-2518 | ||
| 024 | 7 |
_a10.1016/j.vaccine.2017.07.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPrymula, Roman | |
| 245 | 0 | 0 |
_aSafety, reactogenicity and immunogenicity of two investigational pneumococcal protein-based vaccines: Results from a randomized phase II study in infants. _h[electronic resource] |
| 260 |
_bVaccine _c08 2017 |
||
| 300 |
_a4603-4611 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAntibodies, Bacterial _xblood |
| 650 | 0 | 4 |
_aBacterial Proteins _ximmunology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFever _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization, Secondary |
| 650 | 0 | 4 | _aImmunogenicity, Vaccine |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPneumococcal Infections _xprevention & control |
| 650 | 0 | 4 |
_aPneumococcal Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aSerogroup |
| 650 | 0 | 4 |
_aStreptococcus pneumoniae _xchemistry |
| 650 | 0 | 4 |
_aStreptolysins _ximmunology |
| 650 | 0 | 4 | _aVaccination |
| 650 | 0 | 4 |
_aVaccines, Combined _ximmunology |
| 650 | 0 | 4 |
_aVaccines, Conjugate _ximmunology |
| 700 | 1 | _aSzenborn, Leszek | |
| 700 | 1 | _aSilfverdal, Sven-Arne | |
| 700 | 1 | _aWysocki, Jacek | |
| 700 | 1 | _aAlbrecht, Piotr | |
| 700 | 1 | _aTraskine, Magali | |
| 700 | 1 | _aGardev, Asparuh | |
| 700 | 1 | _aSong, Yue | |
| 700 | 1 | _aBorys, Dorota | |
| 773 | 0 |
_tVaccine _gvol. 35 _gno. 35 Pt B _gp. 4603-4611 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2017.07.008 _zAvailable from publisher's website |
| 999 |
_c27388226 _d27388226 |
||